June 2015

There is no doubt that the time is right for a large precision medicine cohort of 1 million people or more due to advances in scientific knowledge, technology and computing, empowerment of patients and the general public, and existing resources of millions of people who already participate in ongoing cohort studies. At a recent workshop, NIH director Dr Francis Collins used examples of early success such as pharmacogenomics tests, new therapeutic targets for common diseases, insights into resilience and healthy aging, and new ways to evaluate m-Health technologies for chronic disease management.

June 2015

There is no doubt that the time is right for a large precision medicine cohort of 1 million people or more due to advances in scientific knowledge, technology and computing, empowerment of patients and the general public, and existing resources of millions of people who already participate in ongoing cohort studies. At a recent workshop, NIH director Dr Francis Collins used examples of early success such as pharmacogenomics tests, new therapeutic targets for common diseases, insights into resilience and healthy aging, and new ways to evaluate m-Health technologies for chronic disease management.

October 2014

A collaborative research team led by the Medical College of Wisconsin scientists has identified a new gene, called Tpcn2, which is associated with fasting glucose and insulin levels in humans, rats and mice. Tpcn2 is a lysosomal calcium channel that likely plays a role in insulin signalling. Glucose tolerance, insulin resistance and beta cell dysfunction are key underlying causes of type 2 diabetes.

September 2014

Researchers from the Broad Institute and Harvard University, in collaboration with the Sierra Leone Ministry of Health and Sanitation and other researchers across institutions and continents, have rapidly sequenced and analysed more than 99 Ebola virus genomes. Their findings could have important implications for rapid field diagnostic tests to combat the unprecedented Ebola outbreak in West Africa.

Back to Newsletters